Archive
Potential contribution of aspirin to cancer control programs
G. Morgan
Abstract
Chemoprevention describes the potential of chemicals to intervene and stop the multistage carcinogenesis. Aspirin (Acetilsalicilato) is showing potential chemopreventivi cancer and medicine has potential for public health, since low-doses also reduce the risk of cardiovascular events up to 30%. While acknowledging that aspirin has undesirable effects, perhaps medicine can compliment other cancer control programs, such as screening and lifestyle measures.In addition, maybe the potential cancer chemopreventivi aspirin could be mediated in part by salicylate which is present in fruits and vegetables.Salicylate might be considered therefore a nutraceutical. Furthermore, there are a number of issues that arise including the potential for the public health sector to further support the agenda prior to self-care, which might include aspirin. Maybe now is appropriate for the potential of public health of aspirin to be convened a Conference.
Keywords:
aspirin, cancer control, salicylate, nutraceutical, public health
Volume: 2 article number: 100 DOI: 10.3332/100 ecancer. 2008. received: 12/10/2008 published: 12/11/2008
To view this article in its entirety, you must first sign in or register.
Cell fusion as a potential target for cancer therapy
J.M. Gasent-Blesa, V.A. Candel
In the fight against cancer, we need new and more specific objectives. Here we offer an example of a potential target that has not been studied, namely, the protein syncytin. Syncytin is expressed mainly in the placenta and is involved in cell fusion in placenta syncytiotrophoblast.Not much is known about the role of syncytin in cancer, but existing data call for more intense research. retroviral origins and distribution of tissue particular make syncytin an interesting target potential in cancer therapy.
Volume: 3 article number: 145 DOI: 10.3332/ecancer may.2009.145 received: 17/05/2009 published: 06/08/2009
To view this article in its entirety, you must first sign in or register.
Intraprostatic fiducial markers: a potential application for radiotherapy ultrasound guided in prostate cancer
R. Vavassori, B.A. Jereczek-pit, d. Zerini, l. De Cicco, r. Cambria, f. Cattani, c. Garibaldi, m. Ciocca, r. Orecchia
Report on a two-phase test performed to evaluate the ability of B-based ultrasound and target acquisition mode (BAT) trans-abdominal system to identify indicators of reference not dedicated implanted in the prostate to next image-guided tours-radiotherapy.
Although further investigation is justified in order to locate the optimal echogenic marker and to define its potential use for image-guided tours-radiotherapy in patients with prostate cancer, we must demonstrate the viability of the system to display markers not dedicated U.S. BAT.
Volume: 3 article number: 143 DOI: 10.3332/ecancer may.2009.143 received: 22/04/2009 published: 12/05/2009
To view this article in its entirety, you must first sign in or register.
cancer3 